Diagnosis and Management of Amyloidosis
JAMA Clinical Reviews
English - July 07, 2020 15:00 - 28 minutes - 26.3 MB - ★★★★★ - 413 ratingsMedicine Health & Fitness Science clinicalpractice healthcare medical medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: A Clinical Pharmacologist's Perspective on Penicillin Allergy
Next Episode: Acute Kidney Injury Caused by Proton Pump Inhibitors
Although there are only about 4000 new cases of amyloidosis in the US per year, it can cause preserved ejection fraction heart failure, kidney and liver failure, and neuropathy. Amyloidosis is easily diagnosed and treatable, and it should be considered in the differential diagnosis for these diseases. Morie A. Gertz, MD, from the Mayo Clinic in Rochester, Minnesota, talks with JAMA Clinical Reviews about amyloidosis.
Related: